Cadonilimab Plus Chemotherapy in LACC: A Prospective, Multicenter, Randomized Phase II Trial | MicrobiomeTrials← Back to trialsNCT07649174
Cadonilimab Plus Chemotherapy in LACC: A Prospective, Multicenter, Randomized Phase II Trial
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-06Est. Completion: 2028-12-31
Enrollment target: 134 participants Locations- Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
Other microbiome trials you might be interested in
Endocrine TumorsThyroid NeoplasmsParathyroid NeoplasmsAdrenal NeoplasmNeuroblastoma
Background:
* Endocrine neoplasms (tumors) are among the fastest growing tumors in incidence in the United States. Furt…
Bethesda, United States
Anesthesia
To study the influence of anaesthesia (local by cervical block vs. general or spinal anaesthesia) on height and volume o…
Amiens, FranceCompleted Jan 1, 2017
Completed
This randomized controlled trial was conducted to evaluate the effect of a web-based interactive nurse support program b…
Sivas, Turkey (Türkiye)Completed Feb 20, 2025